dpp 4 inhibitor and glp 1 agonist Glucagon-like peptide-1 GLP 1 Receptor Agonists and

The potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing [abstract]

The study made headlines at the 2026 American Society of Clinical Oncology (ASCO) annual meeting in June

Examination of absolute standardised mean differences for all the seven trials after weighting showed that all absolute values of standardised mean differences were below 0.1 suggesting good balance between the GLP-1 receptor agonist and the SGLT-2 inhibitor groups (see supplementary figure S3 for trial 1 and supplementary figure S4 for trials 2-7)

Synaptic Dysfunction and Memory Loss in Depression and Its Relation to GLP-1 In patients with depression, neural circuits are impaired as a result of aberrant communication between neurons (Williams, 2016)

25 In the early 1990s, despite John Engs team identifying a potential diabetes treatment in exendin-4, it initially lacked attention and funding for development